Which has grown faster, HUMA or LNSR?

Over the past five years, LNSR grew revenue faster — HUMA at a 2.41% CAGR versus LNSR at 14.67%.

Is HUMA or LNSR more profitable?

LNSR runs the higher net margin — HUMA at -4560.82% versus LNSR at 57.57%.

How have HUMA and LNSR total returns compared?

Over the past 5 years, HUMA delivered -45.73% and LNSR delivered -3.18% annualized total return. Past performance doesn't predict future results.

Humacyte, Inc. (HUMA) vs LENSAR Inc (LNSR)

A side-by-side comparison of Humacyte, Inc. and LENSAR Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HUMA

Humacyte, Inc.

$85M

$0.51HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT

LNSR

LENSAR Inc

$82M

$6.70HealthcareDelayed quote: Oct 6, 2026, 11:48 AM EDT

Total return — HUMA vs LNSR

growth of $100 · dividends reinvested · last 6y

HUMA -94.8% (-39.0%/yr)LNSR -22.2% (-4.1%/yr)LNSR compounded faster over this window

Log scale — wide-divergence pair

HUMA LNSR

HUMA vs LNSR: by the numbers

•HUMA is the larger company ($85M vs $82M market cap).
•LNSR is profitable (57.57% net margin) while HUMA runs a net loss (-4560.82%).
•LNSR grew revenue faster over the past five years (14.67% vs 2.41% CAGR).

Metrics side by side

Valuation

Metric	HUMA	LNSR
P/S ratio	40.11	1.37
P/B ratio	2.72	5.52

Profitability

Metric	HUMA	LNSR
Gross margin	-736.46%	47.96%
Operating margin	-5271.69%	-42.06%
Net margin	-4560.82%	57.57%
ROE	-309.44%	232.78%
ROIC	-90.27%	-16.28%

Growth (annualized)

Metric	HUMA	LNSR
Revenue CAGR (5Y)	2.41%	14.67%
Total return CAGR (5Y)	-45.73%	-3.18%

Frequently asked

Which has grown faster, HUMA or LNSR?: Over the past five years, LNSR grew revenue faster — HUMA at a 2.41% CAGR versus LNSR at 14.67%.
Is HUMA or LNSR more profitable?: LNSR runs the higher net margin — HUMA at -4560.82% versus LNSR at 57.57%.
How have HUMA and LNSR total returns compared?: Over the past 5 years, HUMA delivered -45.73% and LNSR delivered -3.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUMA analysis Full LNSR analysis Interactive comparison tool

Dig into the metrics

Humacyte ROE LENSAR ROE Humacyte operating margin LENSAR operating margin Humacyte revenue growth LENSAR revenue growth Humacyte free cash flow LENSAR free cash flow

Humacyte & LENSAR appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.